Clemastine

4 trials 2 recruiting RRespiratory

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

2 Recruiting

2 Completed trials

4 Sponsors

6 Countries

Phase III

Phase II

Phase IV

Phase I (FiH)

Phase III: 1 Phase II: 1 Phase IV: 1 Phase I (FiH): 1

Oversight events:

1 temporary halt across 1 trial

View oversight register →

Indications tested

Schizophrenia 1

Sponsors using this IMP

Amsterdam UMC Stichting 1 BioInvent International AB 1 Klinikum der Universitaet Muenchen AöR 1 Universitair Medisch Centrum Groningen 1

All trials

4 total

method VALIDation and evaluation of non-radioactive methods to measure Glomerular Filtration Rate Recruiting

2023-509156-34-02 Phase IV 1 country Universitair Medisch Centrum Groningen
Combining Clemastine and Aerobic Exercise to Treat Cognitive Dysfunction in Schizophrenia by Targeting Myelin Plasticity (OligoTreat) Recruiting

2024-514457-30-00 Phase II 1 country Klinikum der Universitaet Muenchen AöR
Phase 1/2a Open-Label, Dose-Escalation, Multicenter, First in-Human, Consecutive-Cohort, Clinical Trial of BI 1910, a Monoclonal Antibody to… Ended

2022-503066-74-00 Phase I (FiH) 5 countries Bioinvent International AB
Clemastine fumarate as remyelinating treatment in internuclear ophthalmoparesis and multiple sclerosis Ended

2024-513099-17-00 Phase III 1 country Amsterdam UMC Stichting

Showing 1–4 of 4 trials

← All drugs A–Z